These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38249624)

  • 1. Retracted: The Role of Gender-Related Immune Genes in Childhood Acute Myeloid Leukemia.
    International BR
    Biomed Res Int; 2024; 2024():9824385. PubMed ID: 38249624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retracted: Research Progress of B-Cell Lymphoma/Leukemia-2 Inhibitor Combined with Azacytidine in the Targeted Therapy of Acute Myeloid Leukemia.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9837485. PubMed ID: 37829540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: Clinical Significance of EZH2 in Acute Myeloid Leukemia.
    Intelligence And Neuroscience C
    Comput Intell Neurosci; 2023; 2023():9761597. PubMed ID: 37800055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: Regulatory Networks of Prognostic mRNAs in Pediatric Acute Myeloid Leukemia.
    Healthcare Engineering JO
    J Healthc Eng; 2022; 2022():9824012. PubMed ID: 36561372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: lncRNA GAS5 Induces Cell Apoptosis in Acute Myeloid Leukemia by Targeting Nrf2.
    Markers D
    Dis Markers; 2023; 2023():9808761. PubMed ID: 37502590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: MicroRNA-1306-5p Regulates the METTL14-Guided m6A Methylation to Repress Acute Myeloid Leukemia.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9831697. PubMed ID: 38124948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Analysis of the Clinical Efficacy of Azacytidine + Venetoclax in the Treatment of Elderly Patients with Relapsed Refractory Acute Myeloid Leukemia.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9840736. PubMed ID: 37829626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: Expression and Regulation Network of HDAC3 in Acute Myeloid Leukemia and the Implication for Targeted Therapy Based on Multidataset Data Mining.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9789343. PubMed ID: 38094462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9823939. PubMed ID: 37593493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: Application Value of Metagenomics Next-Generation Sequencing (mNGS) in Detection of Mucormycosis after Chemotherapy in Childhood Acute Leukemia.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9764181. PubMed ID: 37565218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Antileukemic Effects of Anti-miR-146a, Anti-miR-155, Anti-miR-181a, and Prednisolone on Childhood Acute Lymphoblastic Leukemia.
    International BR
    Biomed Res Int; 2024; 2024():9832739. PubMed ID: 38230099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Treatment of Cancer Gene Changes in Chronic Myeloid Leukemia by Big Data Analysis Platform-Based Dasatinib.
    And Biomechanics AB
    Appl Bionics Biomech; 2023; 2023():9804128. PubMed ID: 38075084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: lncRNA HOTTIP Recruits EZH2 to Inhibit PTEN Expression and Participates in IM Resistance in Chronic Myeloid Leukemia.
    International SC
    Stem Cells Int; 2023; 2023():9760693. PubMed ID: 37829611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Second-Generation Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia Patients with Stable Deep Molecular Response: A Systematic Review and a Meta-Analysis.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9789318. PubMed ID: 37416159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: LncRNA-PAX8-AS1 Silencing Decreases Cell Viability, Enhances Apoptosis, and Suppresses Doxorubicin Resistance in Myeloid Leukemia via the miR-378g/ERBB2 Axis.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9829428. PubMed ID: 37387868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Two Different Transplant Preconditioning Regimens Combined with Irradiation and Chemotherapy in the Treatment of Childhood Leukemia: Systematic Review and Meta-Analysis.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9862546. PubMed ID: 37799649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RETRACTED: Jain et al. Lysosomes in Stem Cell Quiescence: A Potential Therapeutic Target in Acute Myeloid Leukemia.
    Jain V; Bose S; Arya AK; Arif T
    Cancers (Basel); 2024 Jun; 16(13):. PubMed ID: 39001556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Role and Mechanism of lncRNA-pvt1 in the Pathogenesis of Acute Lymphoblastic Leukemia in Children.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9803794. PubMed ID: 37416168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Genomic and Clinical Analysis of Children with Acute Lymphoblastic Leukemia.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9780586. PubMed ID: 37475906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Abnormal GRHL2 Methylation Confers Malignant Progression to Acute Leukemia.
    And Biomechanics AB
    Appl Bionics Biomech; 2023; 2023():9837924. PubMed ID: 37621484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.